Results from TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) have been published. Reported by Klareskog et al (Lancet 363: 675, 2004), this multicenter double-blind trial comparing the combination of methotrexate + etanercept to either methotrexate or etanercept alone involved 682 patients with established RA at 92 centers in Europe and Australia. The results were previously reported at the 2003 Annual European Congress of Rheumatology.
Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.
Use of this Site
All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.